IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 144 filers reported holding IMMUNOMEDICS INC in Q2 2017. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $167,888,000 | -59.1% | 1,974,455 | -83.0% | 0.02% | -62.2% |
Q2 2020 | $410,766,000 | +620.4% | 11,590,471 | +174.0% | 0.04% | +462.5% |
Q1 2020 | $57,023,000 | -41.6% | 4,230,213 | -8.3% | 0.01% | -27.3% |
Q4 2019 | $97,666,000 | +5.0% | 4,615,579 | -34.2% | 0.01% | 0.0% |
Q3 2019 | $93,006,000 | -47.1% | 7,014,021 | -44.7% | 0.01% | -47.6% |
Q2 2019 | $175,819,000 | -60.0% | 12,676,130 | -44.6% | 0.02% | -60.4% |
Q1 2019 | $439,291,000 | +273.8% | 22,867,854 | +177.7% | 0.05% | +231.2% |
Q4 2018 | $117,519,000 | +1.5% | 8,235,480 | +48.2% | 0.02% | +23.1% |
Q3 2018 | $115,778,000 | -42.4% | 5,558,234 | -34.6% | 0.01% | -43.5% |
Q2 2018 | $201,057,000 | +76.6% | 8,494,182 | +9.0% | 0.02% | +64.3% |
Q1 2018 | $113,878,000 | +47.4% | 7,794,524 | +63.0% | 0.01% | +55.6% |
Q4 2017 | $77,252,000 | +0.5% | 4,780,451 | -13.0% | 0.01% | 0.0% |
Q3 2017 | $76,846,000 | +58.3% | 5,496,851 | 0.0% | 0.01% | +50.0% |
Q2 2017 | $48,537,000 | +392.1% | 5,496,851 | +260.6% | 0.01% | +500.0% |
Q1 2017 | $9,863,000 | +137.3% | 1,524,463 | +34.6% | 0.00% | 0.0% |
Q4 2016 | $4,157,000 | +12.9% | 1,132,648 | 0.0% | 0.00% | – |
Q3 2016 | $3,681,000 | +40.1% | 1,132,648 | 0.0% | 0.00% | – |
Q2 2016 | $2,628,000 | -90.6% | 1,132,648 | -89.9% | 0.00% | -100.0% |
Q1 2016 | $27,915,000 | -30.7% | 11,166,048 | -14.9% | 0.00% | -20.0% |
Q4 2015 | $40,288,000 | +65.0% | 13,123,198 | -7.5% | 0.01% | +66.7% |
Q3 2015 | $24,413,000 | -57.1% | 14,193,886 | +1.2% | 0.00% | -57.1% |
Q2 2015 | $56,920,000 | +7.5% | 14,019,669 | +1.4% | 0.01% | 0.0% |
Q1 2015 | $52,973,000 | -20.8% | 13,830,947 | -0.7% | 0.01% | -22.2% |
Q4 2014 | $66,869,000 | +30.2% | 13,930,947 | +0.9% | 0.01% | +28.6% |
Q3 2014 | $51,361,000 | +2.4% | 13,806,852 | +0.5% | 0.01% | 0.0% |
Q2 2014 | $50,141,000 | -4.7% | 13,737,152 | +9.9% | 0.01% | 0.0% |
Q1 2014 | $52,602,000 | -8.3% | 12,494,669 | +0.2% | 0.01% | -12.5% |
Q4 2013 | $57,362,000 | -25.5% | 12,470,142 | +0.2% | 0.01% | -33.3% |
Q3 2013 | $77,006,000 | +23.7% | 12,440,343 | +8.7% | 0.01% | +20.0% |
Q2 2013 | $62,233,000 | – | 11,439,971 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Avoro Capital Advisors LLC | 10,488,076 | $92,610,000 | 11.69% |
First Light Asset Management, LLC | 2,048,643 | $18,090,000 | 6.07% |
Foresite Capital Management III, LLC | 1,940,850 | $17,138,000 | 5.60% |
DAFNA Capital Management LLC | 637,700 | $5,631,000 | 4.02% |
ACUTA CAPITAL PARTNERS, LLC | 1,600,000 | $14,128,000 | 3.95% |
Opaleye Management Inc. | 900,000 | $7,947,000 | 3.32% |
Ghost Tree Capital, LLC | 1,200,000 | $10,596,000 | 2.20% |
Iguana Healthcare Management, LLC | 325,000 | $2,870,000 | 1.62% |
Healthcare Value Capital, LLC | 100,000 | $883,000 | 1.59% |
Palo Alto Investors LP | 3,010,466 | $26,582,000 | 1.24% |